Skip to main content

Advertisement

Log in

Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Introduction

Survival in elderly patients undergoing mastectomy or lumpectomy has not been specifically analyzed.

Methods

Patients older than 70 years of age with clinical stage I invasive breast cancer, undergoing mastectomy or lumpectomy with or without radiation, and surveyed within 3 years of their diagnosis, were identified from the Surveillance, Epidemiology, and End Results and medicare health outcomes survey-linked dataset. The primary endpoint was breast cancer-specific survival (CSS).

Results

Of 1784 patients, 596 (33.4 %) underwent mastectomy, 918 (51.4 %) underwent lumpectomy with radiation, and 270 (15.1 %) underwent lumpectomy alone. Significant differences were noted in age, tumor size, American Joint Committee on Cancer (AJCC) stage, lymph node status (all p < 0.0001) and number of positive lymph nodes between the three groups (p = 0.003). On univariate analysis, CSS for patients undergoing lumpectomy with radiation [hazard ratio (HR) 0.61, 95 % confidence interval (CI) 0.43–0.85; p = 0.004] was superior to mastectomy. Older age (HR 1.3, 95 % CI 1.09–1.45; p = 0.002), two or more comorbidities (HR 1.57, 95 % CI 1.08–2.26; p = 0.02), inability to perform more than two activities of daily living (HR 1.61, 95 % CI 1.06–2.44; p = 0.03), larger tumor size (HR 2.36, 95 % CI 1.85–3.02; p < 0.0001), and positive lymph nodes (HR 2.83, 95 % CI 1.98–4.04; p < 0.0001) were associated with worse CSS. On multivariate analysis, larger tumor size (HR 1.89, 95 % CI 1.37–2.57; p < 0.0001) and positive lymph node status (HR 1.99, 95 % CI 1.36–2.9; p = 0.0004) independently predicted worse survival.

Conclusions

Elderly patients with early-stage invasive breast cancer undergoing breast conservation have better CSS than those undergoing mastectomy. After adjusting for comorbidities and functional status, survival is dependent on tumor-specific variables. Determination of lymph node status remains important in staging elderly breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, et al. SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda, MD, based on November 2014 SEER data submission, posted to the SEER web site, April 2015. http://seer.cancer.gov/csr/1975_2012/sections.html.

  2. Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  3. Lichter AS, Lippman ME, Danforth DN Jr, d’Angelo T, Steinberg SM, deMoss E, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol. 1992;10:976–83.

    CAS  PubMed  Google Scholar 

  4. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.

    Article  PubMed  Google Scholar 

  5. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, et al. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg. 2009;209:425–33.e2.

    Google Scholar 

  6. Lee MC, Rogers K, Griffith K, Diehl KA, Breslin TM, Cimmino VM, et al. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009;15:34–40.

    Article  PubMed  Google Scholar 

  7. Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer. 2013;119:1402–11.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;149:267–74.

    Article  PubMed  Google Scholar 

  9. Hofvind S, Holen, Aas T, Roman M, Sebuodegard S, Akslen LA. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. Eur J Surg Oncol. 2015;41:1417–22.

    Article  CAS  PubMed  Google Scholar 

  10. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061–7.

    Article  CAS  PubMed  Google Scholar 

  11. Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P, et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003;21:3580–7.

    Article  PubMed  Google Scholar 

  12. Bouchardy C, Rapiti E, Blagojevic S, Vlastos AT, Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol. 2007;25:1858–69.

    Article  PubMed  Google Scholar 

  13. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000;92:550–6.

    Article  CAS  PubMed  Google Scholar 

  14. Pierga J-Y, Girre V, Laurence V, Asselain B, Diéras V, Jouve M, et al. Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age. Breast. 2004;13:369–75.

    Article  PubMed  Google Scholar 

  15. Smith BD, Jiang J, McLaughlin SS, Hurria A, Smith GL, Giordano SH, et al. Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol. 2011;29:4647–53.

    Article  PubMed  Google Scholar 

  16. Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28:2038–45.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Montroni I, Rocchi M, Santini D, Ceccarelli C, Ghignone F, Zattoni D, et al. Has breast cancer in the elderly remained the same over recent decades? A comparison of two groups of patients 70 years or older treated for breast cancer twenty years apart. J Geriatr Oncol. 2014;5:260–5.

    Article  PubMed  Google Scholar 

  18. Ambs A, Warren JL, Bellizzi KM, Topor M, Haffer SC, Clauser SB. Overview of the SEER–Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev. 2008;29:5–21.

    PubMed  PubMed Central  Google Scholar 

  19. Kent EE, Ambs A, Mitchell SA, Clauser SB, Smith AW, Hays RD. Health-related quality of life in older adult survivors of selected cancers: data from the SEER-MHOS linkage. Cancer. 2015;121:758–65.

    Article  PubMed  Google Scholar 

  20. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. New York: Springer; 2002.

    Book  Google Scholar 

  21. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: World Health Organization; 2008.

    Google Scholar 

  22. Fritz AG. International classification of diseases for oncology (ICD-O). Geneva: World Health Organization; 2000.

    Google Scholar 

  23. Wallace M, Shelkey M. Katz index of independence in activities of daily living (ADL). Urol Nurs. 2007;27:93–4.

    PubMed  Google Scholar 

  24. Arias E. United States life tables, 2010. Natl Vital Stat Rep. 2014;63:1–62.

    PubMed  Google Scholar 

  25. Klepin H, Mohile S, Hurria A. Geriatric assessment in older patients with breast cancer. J Natl Compr Cancer Netw. 2009;7:226–36.

    PubMed  PubMed Central  Google Scholar 

  26. Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16:266–73.

    Article  PubMed  Google Scholar 

  28. Fyles AW, Mccready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351:963–70.

    Article  CAS  PubMed  Google Scholar 

  29. Potter R, Gnant M, Kwasny W, Tausch C, Handl-Zeller L, Pakisch B, et al. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys. 2007;68:334–40.

    Article  PubMed  Google Scholar 

  30. Soulos PR, Yu JB, Roberts KB, Raldow AC, Herrin J, Long JB, et al. Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol. 2012;30:1601–7.

    Article  PubMed  PubMed Central  Google Scholar 

  31. McCormick B, Ottesen RA, Hughes ME, Javid SH, Khan SA, Mortimer J, et al. Impact of guideline changes on use or omission of radiation in the elderly with early breast cancer: practice patterns at National Comprehensive Cancer Network institutions. J Am Coll Surg. 2014;219:796–802.

    Article  Google Scholar 

  32. NCCN clinical practice guidelines in oncology (NCCN Guidelines®), Breast Cancer. Version 1.2014. www.NCCN.com (2014).

  33. Rudenstam C-M, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006;24:337–44.

    Article  PubMed  Google Scholar 

  34. Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.

    Article  Google Scholar 

  35. Jagsi R, Abrahamse P, Hawley ST, Graff JJ, Hamilton AS, Katz SJ. Under ascertainment of radiotherapy receipt in surveillance, epidemiology, and end results registry data. Cancer. 2012;118:333–41.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by Wake Forest University Biostatistics shared resource NCI CCSG P30CA012197.

Conflicts of interest

Harveshp D. Mogal, Clancy Clark, Rebecca Dodson, Nora F. Fino, and Marissa Howard-McNatt have no conflicts of interest to declare.

Ethics statement

Institutional Review Board approval was obtained for this study.

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marissa Howard-McNatt MD.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (MP3 2683 kb)

Supplementary material 2 (MP3 2916 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mogal, H.D., Clark, C., Dodson, R. et al. Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage Breast Cancer. Ann Surg Oncol 24, 100–107 (2017). https://doi.org/10.1245/s10434-016-5582-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5582-8

Keywords

Navigation